IPP Bureau
IMCD Colombia acquires pharma API distributor Allianz
By IPP Bureau - May 03, 2023
Allianz is ISO 9001:2015 certified and INVIMA certified for storage, sampling, dispensation, and distribution of APIs to the Colombian market
CPHI & PMEC China 2023 to see surge from pent up international ingredients demand
By IPP Bureau - May 03, 2023
China recorded unprecedented improvement in its API manufacturing score in the 2022 end of year CPHI Survey
Healthium Medtech appoints Prashant Krishnan as Global Business Head for Advanced Wound Care and Surgery
By IPP Bureau - May 02, 2023
The strategic appointment is also critical to reinforcing Healthium’s market leadership, corporate governance and deep domain expertis
Majority of UK physicians believe Brexit aggravated NHS staff shortage crisis: GlobalData
By IPP Bureau - May 02, 2023
Brexit had a negative impact on NHS staff shortages and worsened the workforce crisis
Lilly's Lebrikizumab shows improved face or hand dermatitis
By IPP Bureau - May 02, 2023
Lebrikizumab is an investigational high-affinity and potent IL-13 inhibitor being studied in adult and adolescent patients
CHMP recommends EU approval of Roche’s fixed-duration Columvi for large B-cell lymphoma
By IPP Bureau - May 02, 2023
Once approved, Columvi will be the first CD20xCD3 T-cell-engaging bispecific antibody available to treat people in Europe with this aggressive lymphoma
Innocan Pharma announces expansion to Lithuania, Latvia & Estonia markets
By IPP Bureau - May 02, 2023
UAB Medexy's first order under the Distribution Agreement is for over 5000 units of SHIR and RELIEF&GO products
Mitsui Chemicals ‘Super-Bond’ dental adhesive to launch in Brazil
By IPP Bureau - May 01, 2023
Super-Bond is made up of a polymerization initiator, a liquid and a polymer powder
Aptar Digital Health and Healint collaborate for Central Nervous System
By IPP Bureau - May 01, 2023
The partnership will capitalize on the combined capabilities of the two organizations
Kokilaben Hospital launches dedicated Hereditary Cancer Clinic
By IPP Bureau - May 01, 2023
Clinic will offer Comprehensive Genetic Counselling and Testing Services to empower patients with personalized care
IOL Chemicals and Pharmaceuticals reports Q4 FY23 PAT at Rs. 65 Cr
By IPP Bureau - May 01, 2023
Net profit for FY23 at Rs. 140 crore as compared to Rs. 166 crore in FY22
Biocon Biologics' new mAbs facility receives EU GMP Certification for bBevacizumab
By IPP Bureau - April 29, 2023
This approval reflects Biocon Biologics' compliance with the highest international regulatory standards
RPG Life Sciences posts Q4 revenue at Rs 118.49 Cr
By IPP Bureau - April 29, 2023
Revenue from operations at Rs 512.81 crores registered a growth of 17% Y-o-Y for full year FY23
Atul appoints Rangaswamy Iyer as Independent Director
By IPP Bureau - April 29, 2023
The appointment is effective from May 01, 2023 for five years
Evonik starts construction of new U.S. facility for pharmaceutical lipids
By IPP Bureau - April 29, 2023
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
